(Q43515854)

English

Non-toxic Pseudomonas aeruginosa exotoxin A expressing the FMDV VP1 G-H loop for mucosal vaccination of swine against foot and mouth disease virus

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Non-toxic Pseudomonas aeruginosa exotoxin A expressing the FMDV VP1 G-H loop for mucosal vaccination of swine against foot and mouth disease virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Pseudomonas aeruginosa

0 references

1 reference

based on heuristic

inferred from title

author name string

Sreerupa Challa

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Roger Barrette

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Debra Rood

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

John Zinckgraf

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Richard French

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Lawrence Silbart

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

12 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

3328-3337

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Foot-and-mouth disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Structure and receptor binding.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Integrin-alphavbeta6, a putative receptor for foot-and-mouth disease virus, is constitutively expressed in ruminant airways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Structure of a major immunogenic site on foot-and-mouth disease virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Induced pocket to accommodate the cell attachment Arg-Gly-Asp motif in a neutralizing antibody against foot-and-mouth-disease virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Intranasal immunization of guinea pigs with an immunodominant foot-and-mouth disease virus peptide conjugate induces mucosal and humoral antibodies and protection against challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Evidence of the coevolution of antigenicity and host cell tropism of foot-and-mouth disease virus in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Fusion proteins with multiple copies of the major antigenic determinant of foot-and-mouth disease virus protect both the natural host and laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

OmpA-FMDV VP1 fusion proteins: production, cell surface exposure and immune responses to the major antigenic domain of foot-and-mouth disease virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Localization of foot-and-mouth disease virus RNA by in situ hybridization within bovine tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Exotoxin A of Pseudomonas aeruginosa: evidence that domain I functions in receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Bacterial toxins as tools for mucosal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

1st class ticket to class I: protein toxins as pathfinders for antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

LRP 1 B functions as a receptor for Pseudomonas exotoxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Insight into the catalytic mechanism of Pseudomonas aeruginosa exotoxin A. Studies of toxin interaction with eukaryotic elongation factor-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Conformational integrity of a recombinant toxoid of Pseudomonas aeruginosa exotoxin A containing a deletion of glutamic acid-553

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Mucosal administration of a chimera composed of Pseudomonas exotoxin and the gp120 V3 loop sequence of HIV-1 induces both salivary and serum antibody responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Characterization of V3 loop-Pseudomonas exotoxin chimeras. Candidate vaccines for human immunodeficiency virus-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Early phase II trial of human rotavirus vaccine candidate RV3

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Effective synthetic peptide vaccine for foot-and-mouth disease in swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Delivery of antigens to the MHC class I pathway using bacterial toxins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Pseudomonas exotoxin-mediated delivery of exogenous antigens to MHC class I and class II processing pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.006

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.01.006

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43515854&oldid=1990322502"